Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.91 USD | -3.54% | +0.53% | -3.54% |
Mar. 08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Mar. 05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.54% | 171M | |
+4.09% | 43.84B | |
+46.17% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- CGEN Stock
- News Compugen Ltd.
- Compugen : Expands Clinical Collaboration With Bristol Myers to Support Its Expansion Study For Cancer Drug